Long-term cognitive treatment of Alzheimer's disease: A single case study

Neuropsychological Rehabilitation

Volumn 16, Issue 1, 2006, Pages 96-109

  Luis Fernández, Alberto ^a,b   Manoiloff, Laura ^a   Monti, Angel ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Instituto de Neurosciencias   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DONEPEZIL; LORAZEPAM; MEMANTINE; PAROXETINE;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CASE REPORT; COGNITIVE REHABILITATION; COMPARATIVE STUDY; CONCEPTUAL FRAMEWORK; DAILY LIFE ACTIVITY; EVALUATION; HUMAN; MALE; MATHEMATICAL MODEL; MEMORY; PERFORMANCE; RATING SCALE; THEORETICAL MODEL; TRAINING; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; ATTENTION; COGNITIVE THERAPY; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644841557     PISSN: 09602011     EISSN: 14640694     Source Type: Journal    
DOI: 10.1080/09602010443000164     Document Type: Article

References (20)

1. Arkin, S. M. (2001). Alzheimer rehabilitation by students: Interventions and outcomes. Neuropsychological Rehabilitation, 11(3-4), 273-318.
2. Barlow, D. H., & Hersen, M. (1988). Diseños experimentales de caso único. [Single case experimental designs]. Barcelona: Martínez Roca.
3. Becker, J. T., Boller, F., López, O. L., Saxton, J., & McGonigle, K. L. (1994). The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis. Archives of Neurology, 51, 585-594.
4. Becker, J. T., Boller, F., Saxton, J., & McGonigle, K. L. (1987). Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex, 23, 59-72.
5. Camp, C. J., Foss, J. W., O'Hanlon, A. M., & Stevens, A. B. (1996). Memory interventions for persons with dementia. Applied Cognitive Psychology, 10, 193-210.
6. Clare, L., Wilson, B. A., Carter, G., & Hodges, J. R. (2003). Cognitive rehabilitation as a component of early intervention in Alzheimer's disease: A single case study. Aging and Mental Health, 7(1), 15-21.
7. Clare, L., Wilson, B. A., Carter, G., Hodges, J. R., & Adams M. (2001). Long-term maintenance of treatment gains following a cognitive rehabilitation intervention in early dementia of Alzheimer type: A single case study. Neuropsychological Rehabilitation, 11(3/4), 477-494.
8. Farina, E., Fioravanti, R., Chiavari, L., Imbornone, E., Alberoni, M., Pomati, S., Pinardi, G., Pignatti, R., & Mariani, C. (2002). Comparing two programs of cognitive training in Alzheimer's disease: A pilot study. Acta Neurologica Scandinavica, 105(5), 365-371.
9. Fernández, A. L., & Scheffel, D. L. (2003). A study of the criterion validity of the Mattis Dementia Rating Scale. International Journal of Testing, 3, 49-58.
10. Kazdin, A. E. (2001). Métodos de investigación en psicología clínica. [Research design in clinical psychology]. México: Pearson Educación.
11. Lopez, O. L.; Becker, J. T.; Wisniewski, S., Saxton, J., Kaufer, D. I., & DeKosky, S. T. (2002). Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 72(3), 310-316.
12. Mattis, S. (1988). Dementia rating scale. Odessa, FL: Psychological Assessment Resources.
13. Newcombe, F. (1969). Missile wounds of the brain. New York, NY: Oxford University Press.
14. Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., Mobius, Hans, J. et al. (2003). Memantine in Moderate-to-severe Alzheimer's disease. New England Journal of Medicine, 348(14), 1333-1341.
15. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Group, T. D. S. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology, 50, 136-145.
16. Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356-1364.
17. Salmon, D. P., Thal, L. J., Butters, N., & Heindel, W. C. (1990). Longitudinal evaluation of dementia of the Alzheimer type: A comparison of three standardized mental status examinations. Neurology, 40, 1225-1230.
18. Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S., & Ding, C. (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology, 54, 2269-2276.
19. Wechsler, D. (1955). Wechsler Adult Intelligence Scale Manual. New York, NY: Psychological Corporation.
20. Winblad, B., Engedeal, K., Soininen, H., Verhey, F., Waldemar, G., Wimo, A., Wetterholm, A. L., Zhang, R., Haglund, A., & Subbiah, P. (2001). A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology, 57, 489-495.